Works matching IS 1021335X AND DT 2022 AND VI 47 AND IP 4
Results: 25
p53 reactivating small molecule PRIMA-1<sup>MET</sup>/APR-246 regulates genomic instability in MDA-MB-231 cells.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8296
- By:
- Publication type:
- Article
In vitro anticancer effects of alpelisib against PIK3CA-mutated canine hemangiosarcoma cell lines.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8295
- By:
- Publication type:
- Article
Cepharanthine hydrochloride inhibits the Wnt/β-catenin/Hedgehog signaling axis in liver cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8294
- By:
- Publication type:
- Article
Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8293
- By:
- Publication type:
- Article
Significance of cancer stroma for bone destruction in oral squamous cell carcinoma using different cancer stroma subtypes.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8292
- By:
- Publication type:
- Article
RASSF10 exhibits tumor-suppressing potential involving tumor proliferation, metastasis and epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8291
- By:
- Publication type:
- Article
Inhibition of cIAP1 in the effective suppression of chemotherapy-resistant hepatoblastoma.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8290
- By:
- Publication type:
- Article
ATR inhibitor AZD6738 increases the sensitivity of colorectal cancer cells to 5-fluorouracil by inhibiting repair of DNA damage.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8289
- By:
- Publication type:
- Article
Inhibition of LDHA suppresses cell proliferation and increases mitochondrial apoptosis via the JNK signaling pathway in cervical cancer cells.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8288
- By:
- Publication type:
- Article
Combination of cannabidiol with low-dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8287
- By:
- Publication type:
- Article
circKL inhibits the growth and metastasis of kidney cancer by sponging miR-182-5p and upregulating FBXW7.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8286
- By:
- Publication type:
- Article
Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8285
- By:
- Publication type:
- Article
Differential expression of PD-L1 and PD-L2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in non-small cell lung cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8284
- By:
- Publication type:
- Article
MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8283
- By:
- Publication type:
- Article
Inhibition of the VEGF signaling pathway attenuates tumor-associated macrophage activity in liver cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8282
- By:
- Publication type:
- Article
Characterization of the nucleotide excision repair pathway and evaluation of compounds for overcoming the cisplatin resistance of non-small cell lung cancer cell lines.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8281
- By:
- Publication type:
- Article
MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8280
- By:
- Publication type:
- Article
Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation-resistant pancreatic cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8279
- By:
- Publication type:
- Article
Exosomes derived from Piwil2-induced cancer stem cells transform fibroblasts into cancer-associated fibroblasts.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8273
- By:
- Publication type:
- Article
Epigenetic therapy with chidamide alone or combined with 5-azacitidine exerts antitumour effects on acute myeloid leukaemia cells in vitro.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8277
- By:
- Publication type:
- Article
MicroRNA-454 inhibits the malignant biological behaviours of gastric cancer cells by directly targeting mitogen-activated protein kinase 1.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8276
- By:
- Publication type:
- Article
High-glucose microenvironment promotes perineural invasion of pancreatic cancer via activation of hypoxia inducible factor 1α.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8275
- By:
- Publication type:
- Article
MicroRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8274
- By:
- Publication type:
- Article
lncRNA-CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8278
- By:
- Publication type:
- Article
Antitumor activity of the dual PI3K/mTOR inhibitor gedatolisib and the involvement of ABCB1 in gedatolisib resistance in canine tumor cells.
- Published in:
- Oncology Reports, 2022, v. 47, n. 4, p. N.PAG, doi. 10.3892/or.2022.8272
- By:
- Publication type:
- Article